Award recordCONTRACT

SIRTEX MEDICAL INC

PIID 36C24825P0020· VHA· 248-NETWORK CONTRACT OFFICE 8 (36C248)· 6505 · DRUGS AND BIOLOGICALS· FY2025· $36,690 net obligations· UEI CWH2GM13A2V6· MA

Description

DE-OBLIGATION OF FUNDS - SIR-SPHERES Y90 RESIN MICROSPHERES

Base award description: TEN (10) SIR-SPHERES Y90 RESIN MICROSPHERES

First action · last action
2024-10-01 · 2025-12-10
Transactions
2
First transaction's obligation
$183,450
Base + all options value (sum of deltas)
$36,690
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION (FAR 13)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$183,450$0Base award · 2024-10-01 · this action $183,450 · running total $183,450Modification P00001 · 2025-12-10 · this action -$146,760 · running total $36,690
  • Base2024-10-01+$183,450= $183,450
  • Mod P000012025-12-10-$146,760= $36,690
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-10-01+$183,450$183,450TEN (10) SIR-SPHERES Y90 RESIN MICROSPHERES
Mod P00001· OTHER ADMINISTRATIVE ACTION2025-12-10−$146,760$36,690DE-OBLIGATION OF FUNDS - SIR-SPHERES Y90 RESIN MICROSPHERES

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI CWH2GM13A2V6)

AwardOffice · PSC / listingNet obligationsFY
36C25926N0384NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$245,194FY2026
36C24826P1090248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$45,825FY2026
36C24826P0903248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$47,962FY2026
36C25926N0187NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$203,300FY2026
36C26226N0179262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$202,940FY2026
36C26226N0180262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$200,940FY2026

Other recipients under 6505 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24826F0207CSL BEHRING L.L.C.248-NETWORK CONTRACT OFFICE 8 (36C248)$183,903FY2026
36C24826P1108ASD SPECIALTY HEALTHCARE, LLC248-NETWORK CONTRACT OFFICE 8 (36C248)$54,600FY2026
36C24826N0511BIOMERIEUX INC248-NETWORK CONTRACT OFFICE 8 (36C248)$61,788FY2026
36C24826N0693MEDI-PHYSICS, INC.248-NETWORK CONTRACT OFFICE 8 (36C248)$111,150FY2026
36C24826D0041PROFOUNDA INC248-NETWORK CONTRACT OFFICE 8 (36C248)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24825P0020_3600_-NONE-_-NONE- · retrieved 2026-09-26.